Miller Joseph M 4
4 · Avalo Therapeutics, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Miller Joseph M
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-31+20,239→ 20,239 totalExercise: $0.72From: 2022-03-31Exp: 2032-03-31→ Common Stock (20,239 underlying)
Footnotes (1)
- [F1]100% of the stock option will immediately vest on the date that it is granted.